VANILLA BLUSH MEDICAL LTDActive

Company number SC434720Private limited companyIncorporated 2012

Key figures

£14,006-36.3%
Net assets 2024/25
-27.4%
Average annual change 2019/20–2024/25
025 k50 k75 k100 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, VANILLA BLUSH MEDICAL LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand108,29486,54213,98620,82117,076
Total assets326,767256,859193,841140,026130,301
Total liabilities—————
Net assets / total equity97,84177,15264,39621,97114,006
Average number of employees56655

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: VANILLA BLUSH MEDICAL LTD

Company

VANILLA BLUSH MEDICAL LTD is a private limited company registered with Companies House under company number SC434720. It was incorporated on 15 Oct 2012. Its status is active. The registered office is in Glasgow (G3). Its nature of business (SIC 2007) is manufacture of men's underwear (14141), manufacture of women's underwear (14142), manufacture of other wearing apparel and accessories n.e.c. (14190).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files small company accounts (filleted). Net assets were £14,006, down 36.3% on the previous year. Cash at bank and in hand was £17,076. The company had an average of 5 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered. 2 of 2 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 5 Mar 2027.